feed,title,long_url,short_url
Benzinga,"Immunovant Could Potentially Be An M&A Target, Writes Analyst",https://benzinga.com/analyst-ratings/analyst-color/23/02/30929519/immunovant-could-potentially-be-an-m-a-target-writes-analyst,https://da.gd/TGYt2
